Eagle Capital Management Adds $66M in UnitedHealth Group Incorporated ($UNH)

Eagle Capital Management has increased its position in UnitedHealth Group Incorporated (NYSE: UNH), adding 158,879 shares according to its latest 13F filing with the SEC. This brings the fund's total holdings in the healthcare giant to 5,859,325 shares, valued at approximately $2.39 billion. The increase represents a 2.79% rise in shares held.

What Changed in Eagle Capital Management's UnitedHealth Group Position

Eagle Capital Management boosted its stake in UnitedHealth Group by 158,879 shares, bringing its total to 5,859,325 shares. This move, reflecting a 2.79% increase, was reported in the latest filing, indicating a continued confidence in the healthcare company.

Other Institutional Activity in UnitedHealth Group

Among UnitedHealth Group's major shareholders, BlackRock, Inc. reduced its holdings by 1,276,021 shares, ending with 73,467,531 shares valued at about $19.88 billion. Vanguard Capital Management LLC maintained its position with 58,870,777 shares worth $15.93 billion. Meanwhile, State Street Corp added 100,016 shares to its holdings, now totaling 45,332,186 shares valued at approximately $12.27 billion. Capital World Investors significantly increased its stake by 5,192,373 shares, reaching 27,783,415 shares valued at $7.52 billion.

UnitedHealth Group Incorporated Stock Up 5.8%

Shares of UnitedHealth Group (NYSE: UNH) are trading around $408.45. The company boasts a market cap of $371 billion and a forward P/E ratio of 19.54, with a beta of 0.65 indicating lower volatility compared to the market. The stock's 52-week range is between $234.60 and $415.98, with a 50-day moving average of $361.04 and a 200-day moving average of $331.04. UnitedHealth Group's current ratio stands at 0.798, with a quick ratio of 0.722 and a debt-to-equity ratio of 73.98.

Recent Earnings

UnitedHealth Group reported revenue of $449.71 billion, growing by 2% year-over-year. The company achieved an EPS of $13.26, with a net margin of 2.68% and a return on equity of 12.18%. The next earnings release is scheduled for July 16, 2026.

Dividend

The company offers an annual dividend rate of $9.28 per share, yielding 2.29%. The dividend payout ratio is 66.57%, reflecting a commitment to returning value to shareholders.

Insider Buying and Selling at UnitedHealth Group Incorporated

Recent insider activity at UnitedHealth Group includes several sales by Patrick Hugh Conway, the CEO of Optum, who sold shares on multiple dates in April and June 2026. Christopher Zaetta, EVP & Chief Legal Officer, also sold shares in June. Conversely, Michele Hooper and Frederick William III McNabb made purchases on April 1, 2026.

Analysts Set New Price Targets

Analysts maintain a positive outlook on UnitedHealth Group. On June 8, 2026, Mizuho and JP Morgan both maintained their 'buy' ratings with price targets of $460 and $466, respectively. Morgan Stanley and B of A Securities also reaffirmed 'buy' ratings on June 4, with targets of $453 and $450. The consensus among analysts is a 'buy' recommendation with a mean target price of $407.38.

About UnitedHealth Group

UnitedHealth Group Incorporated is a leading healthcare company based in Eden Prairie, Minnesota. It operates through four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. The company provides a range of services from care delivery and management to pharmacy benefits and health insurance plans, serving individual consumers, employers, and government programs. Led by CEO Stephen J. Hemsley, UnitedHealth Group employs approximately 390,000 people worldwide.

Bottom Line

Eagle Capital Management's increased stake in UnitedHealth Group signals confidence in the company's future performance. Investors often track such filings to gauge institutional sentiment, though it's important to remember that 13F filings reflect past positions. UnitedHealth Group remains a significant player in the healthcare sector, with analysts maintaining a favorable outlook.